ID   RPAC2_HUMAN             Reviewed;         133 AA.
AC   Q9Y2S0; Q5TBX2; Q96BR3;
DT   01-DEC-2000, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1999, sequence version 1.
DT   10-MAY-2017, entry version 156.
DE   RecName: Full=DNA-directed RNA polymerases I and III subunit RPAC2;
DE            Short=RNA polymerases I and III subunit AC2;
DE   AltName: Full=AC19;
DE   AltName: Full=DNA-directed RNA polymerase I subunit D;
DE   AltName: Full=RNA polymerase I 16 kDa subunit;
DE            Short=RPA16;
DE   AltName: Full=RPC16;
DE   AltName: Full=hRPA19;
GN   Name=POLR1D;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RA   Ye M., Zhang Q., Fu G., Zhou J., Yu Y., Shen Y., Wu J., He K.,
RA   Chen S., Mao M., Chen Z.;
RT   "Human RNA polymerase I 16-kDa subunit.";
RL   Submitted (JUL-1998) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Cerebellum;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15057823; DOI=10.1038/nature02379;
RA   Dunham A., Matthews L.H., Burton J., Ashurst J.L., Howe K.L.,
RA   Ashcroft K.J., Beare D.M., Burford D.C., Hunt S.E.,
RA   Griffiths-Jones S., Jones M.C., Keenan S.J., Oliver K., Scott C.E.,
RA   Ainscough R., Almeida J.P., Ambrose K.D., Andrews D.T.,
RA   Ashwell R.I.S., Babbage A.K., Bagguley C.L., Bailey J., Bannerjee R.,
RA   Barlow K.F., Bates K., Beasley H., Bird C.P., Bray-Allen S.,
RA   Brown A.J., Brown J.Y., Burrill W., Carder C., Carter N.P.,
RA   Chapman J.C., Clamp M.E., Clark S.Y., Clarke G., Clee C.M.,
RA   Clegg S.C., Cobley V., Collins J.E., Corby N., Coville G.J.,
RA   Deloukas P., Dhami P., Dunham I., Dunn M., Earthrowl M.E.,
RA   Ellington A.G., Faulkner L., Frankish A.G., Frankland J., French L.,
RA   Garner P., Garnett J., Gilbert J.G.R., Gilson C.J., Ghori J.,
RA   Grafham D.V., Gribble S.M., Griffiths C., Hall R.E., Hammond S.,
RA   Harley J.L., Hart E.A., Heath P.D., Howden P.J., Huckle E.J.,
RA   Hunt P.J., Hunt A.R., Johnson C., Johnson D., Kay M., Kimberley A.M.,
RA   King A., Laird G.K., Langford C.J., Lawlor S., Leongamornlert D.A.,
RA   Lloyd D.M., Lloyd C., Loveland J.E., Lovell J., Martin S.,
RA   Mashreghi-Mohammadi M., McLaren S.J., McMurray A., Milne S.,
RA   Moore M.J.F., Nickerson T., Palmer S.A., Pearce A.V., Peck A.I.,
RA   Pelan S., Phillimore B., Porter K.M., Rice C.M., Searle S.,
RA   Sehra H.K., Shownkeen R., Skuce C.D., Smith M., Steward C.A.,
RA   Sycamore N., Tester J., Thomas D.W., Tracey A., Tromans A., Tubby B.,
RA   Wall M., Wallis J.M., West A.P., Whitehead S.L., Willey D.L.,
RA   Wilming L., Wray P.W., Wright M.W., Young L., Coulson A., Durbin R.M.,
RA   Hubbard T., Sulston J.E., Beck S., Bentley D.R., Rogers J., Ross M.T.;
RT   "The DNA sequence and analysis of human chromosome 13.";
RL   Nature 428:522-528(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2).
RC   TISSUE=Cervix, Colon, and Eye;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   PROTEIN SEQUENCE OF 1-9 AND 88-98, ACETYLATION AT MET-1, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY.
RC   TISSUE=Ovarian carcinoma;
RA   Bienvenut W.V., Lilla S., von Kriegsheim A., Lempens A., Kolch W.;
RL   Submitted (DEC-2008) to UniProtKB.
RN   [7]
RP   IDENTIFICATION IN THE RNA POL III COMPLEX, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY.
RX   PubMed=12391170; DOI=10.1128/MCB.22.22.8044-8055.2002;
RA   Hu P., Wu S., Sun Y., Yuan C.-C., Kobayashi R., Myers M.P.,
RA   Hernandez N.;
RT   "Characterization of human RNA polymerase III identifies orthologues
RT   for Saccharomyces cerevisiae RNA polymerase III subunits.";
RL   Mol. Cell. Biol. 22:8044-8055(2002).
RN   [8]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-104 (ISOFORM 2), AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [9]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [10]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [11]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22223895; DOI=10.1074/mcp.M111.015131;
RA   Bienvenut W.V., Sumpton D., Martinez A., Lilla S., Espagne C.,
RA   Meinnel T., Giglione C.;
RT   "Comparative large-scale characterisation of plant vs. mammal proteins
RT   reveals similar and idiosyncratic N-alpha acetylation features.";
RL   Mol. Cell. Proteomics 11:M111.015131-M111.015131(2012).
RN   [12]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E.,
RA   Timmerman E., Prieto J., Arnesen T., Sherman F., Gevaert K.,
RA   Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-
RT   terminal acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [13]
RP   VARIANTS TCS2 LYS-47; ILE-50; ARG-51; GLU-52; CYS-56; SER-82 AND
RP   SER-99.
RX   PubMed=21131976; DOI=10.1038/ng.724;
RA   Dauwerse J.G., Dixon J., Seland S., Ruivenkamp C.A., van Haeringen A.,
RA   Hoefsloot L.H., Peters D.J., Boers A.C., Daumer-Haas C., Maiwald R.,
RA   Zweier C., Kerr B., Cobo A.M., Toral J.F., Hoogeboom A.J.,
RA   Lohmann D.R., Hehr U., Dixon M.J., Breuning M.H., Wieczorek D.;
RT   "Mutations in genes encoding subunits of RNA polymerases I and III
RT   cause Treacher Collins syndrome.";
RL   Nat. Genet. 43:20-22(2011).
CC   -!- FUNCTION: DNA-dependent RNA polymerase catalyzes the transcription
CC       of DNA into RNA using the four ribonucleoside triphosphates as
CC       substrates. Common core component of RNA polymerases I and III
CC       which synthesize ribosomal RNA precursors and small RNAs, such as
CC       5S rRNA and tRNAs, respectively.
CC   -!- SUBUNIT: Component of the RNA polymerase I (Pol I) and RNA
CC       polymerase III (Pol III) complexes consisting of at least 13 and
CC       17 subunits, respectively. {ECO:0000250}.
CC   -!- INTERACTION:
CC       O15160:POLR1C; NbExp=11; IntAct=EBI-359498, EBI-1055079;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000250}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q9Y2S0-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q9Y2S0-2; Sequence=VSP_035416;
CC         Note=Contains a phosphoserine at position 104.
CC         {ECO:0000244|PubMed:18669648};
CC   -!- DISEASE: Treacher Collins syndrome 2 (TCS2) [MIM:613717]: A form
CC       of Treacher Collins syndrome, a disorder of craniofacial
CC       development. Treacher Collins syndrome is characterized by a
CC       combination of bilateral downward slanting of the palpebral
CC       fissures, colobomas of the lower eyelids with a paucity of
CC       eyelashes medial to the defect, hypoplasia of the facial bones,
CC       cleft palate, malformation of the external ears, atresia of the
CC       external auditory canals, and bilateral conductive hearing loss.
CC       {ECO:0000269|PubMed:21131976}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the archaeal RpoL/eukaryotic RPB11/RPC19
CC       RNA polymerase subunit family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF077044; AAD27777.1; -; mRNA.
DR   EMBL; AK311833; BAG34775.1; -; mRNA.
DR   EMBL; AL136439; CAI16933.1; -; Genomic_DNA.
DR   EMBL; AL136439; CAI16934.1; -; Genomic_DNA.
DR   EMBL; CH471075; EAX08416.1; -; Genomic_DNA.
DR   EMBL; BC000889; AAH00889.1; -; mRNA.
DR   EMBL; BC015319; AAH15319.1; -; mRNA.
DR   EMBL; BC018528; AAH18528.1; -; mRNA.
DR   CCDS; CCDS9324.1; -. [Q9Y2S0-2]
DR   CCDS; CCDS9325.1; -. [Q9Y2S0-1]
DR   RefSeq; NP_001193488.1; NM_001206559.1.
DR   RefSeq; NP_057056.1; NM_015972.3. [Q9Y2S0-1]
DR   RefSeq; NP_689918.1; NM_152705.2. [Q9Y2S0-2]
DR   RefSeq; XP_005266469.1; XM_005266412.1. [Q9Y2S0-1]
DR   RefSeq; XP_005266471.1; XM_005266414.2. [Q9Y2S0-2]
DR   RefSeq; XP_016876112.1; XM_017020623.1. [Q9Y2S0-2]
DR   UniGene; Hs.507584; -.
DR   UniGene; Hs.735744; -.
DR   ProteinModelPortal; Q9Y2S0; -.
DR   SMR; Q9Y2S0; -.
DR   BioGrid; 119272; 41.
DR   DIP; DIP-27598N; -.
DR   IntAct; Q9Y2S0; 18.
DR   MINT; MINT-1149665; -.
DR   STRING; 9606.ENSP00000302478; -.
DR   iPTMnet; Q9Y2S0; -.
DR   PhosphoSitePlus; Q9Y2S0; -.
DR   BioMuta; POLR1D; -.
DR   SWISS-2DPAGE; Q9Y2S0; -.
DR   EPD; Q9Y2S0; -.
DR   PaxDb; Q9Y2S0; -.
DR   PeptideAtlas; Q9Y2S0; -.
DR   PRIDE; Q9Y2S0; -.
DR   DNASU; 51082; -.
DR   Ensembl; ENST00000302979; ENSP00000302478; ENSG00000186184. [Q9Y2S0-1]
DR   Ensembl; ENST00000399697; ENSP00000382604; ENSG00000186184. [Q9Y2S0-2]
DR   GeneID; 51082; -.
DR   KEGG; hsa:51082; -.
DR   UCSC; uc001uro.4; human. [Q9Y2S0-1]
DR   CTD; 51082; -.
DR   DisGeNET; 51082; -.
DR   GeneCards; POLR1D; -.
DR   GeneReviews; POLR1D; -.
DR   HGNC; HGNC:20422; POLR1D.
DR   HPA; HPA039337; -.
DR   MalaCards; POLR1D; -.
DR   MIM; 613715; gene.
DR   MIM; 613717; phenotype.
DR   neXtProt; NX_Q9Y2S0; -.
DR   OpenTargets; ENSG00000186184; -.
DR   Orphanet; 861; Treacher-Collins syndrome.
DR   PharmGKB; PA134914527; -.
DR   eggNOG; KOG3438; Eukaryota.
DR   eggNOG; COG1761; LUCA.
DR   GeneTree; ENSGT00550000075160; -.
DR   HOGENOM; HOG000179862; -.
DR   HOVERGEN; HBG001176; -.
DR   InParanoid; Q9Y2S0; -.
DR   KO; K03020; -.
DR   OMA; NELMDVC; -.
DR   OrthoDB; EOG091G0STX; -.
DR   PhylomeDB; Q9Y2S0; -.
DR   TreeFam; TF103035; -.
DR   Reactome; R-HSA-1834949; Cytosolic sensors of pathogen-associated DNA.
DR   Reactome; R-HSA-427413; NoRC negatively regulates rRNA expression.
DR   Reactome; R-HSA-5250924; B-WICH complex positively regulates rRNA expression.
DR   Reactome; R-HSA-73762; RNA Polymerase I Transcription Initiation.
DR   Reactome; R-HSA-73772; RNA Polymerase I Promoter Escape.
DR   Reactome; R-HSA-73777; RNA Polymerase I Chain Elongation.
DR   Reactome; R-HSA-73780; RNA Polymerase III Chain Elongation.
DR   Reactome; R-HSA-73863; RNA Polymerase I Transcription Termination.
DR   Reactome; R-HSA-73980; RNA Polymerase III Transcription Termination.
DR   Reactome; R-HSA-749476; RNA Polymerase III Abortive And Retractive Initiation.
DR   Reactome; R-HSA-76061; RNA Polymerase III Transcription Initiation From Type 1 Promoter.
DR   Reactome; R-HSA-76066; RNA Polymerase III Transcription Initiation From Type 2 Promoter.
DR   Reactome; R-HSA-76071; RNA Polymerase III Transcription Initiation From Type 3 Promoter.
DR   ChiTaRS; POLR1D; human.
DR   GeneWiki; POLR1D; -.
DR   GenomeRNAi; 51082; -.
DR   PRO; PR:Q9Y2S0; -.
DR   Proteomes; UP000005640; Chromosome 13.
DR   Bgee; ENSG00000186184; -.
DR   CleanEx; HS_POLR1D; -.
DR   ExpressionAtlas; Q9Y2S0; baseline and differential.
DR   Genevisible; Q9Y2S0; HS.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0005736; C:DNA-directed RNA polymerase I complex; IBA:GO_Central.
DR   GO; GO:0005666; C:DNA-directed RNA polymerase III complex; IBA:GO_Central.
DR   GO; GO:0005654; C:nucleoplasm; TAS:Reactome.
DR   GO; GO:0003677; F:DNA binding; IEA:InterPro.
DR   GO; GO:0003899; F:DNA-directed 5'-3' RNA polymerase activity; IEA:UniProtKB-KW.
DR   GO; GO:0046983; F:protein dimerization activity; IEA:InterPro.
DR   GO; GO:0045815; P:positive regulation of gene expression, epigenetic; TAS:Reactome.
DR   GO; GO:0032481; P:positive regulation of type I interferon production; TAS:Reactome.
DR   GO; GO:0006363; P:termination of RNA polymerase I transcription; TAS:Reactome.
DR   GO; GO:0006362; P:transcription elongation from RNA polymerase I promoter; TAS:Reactome.
DR   GO; GO:0006383; P:transcription from RNA polymerase III promoter; IEA:GOC.
DR   GO; GO:0006361; P:transcription initiation from RNA polymerase I promoter; TAS:Reactome.
DR   CDD; cd07029; RNAP_I_III_AC19; 1.
DR   InterPro; IPR009025; RBP11-like_dimer.
DR   InterPro; IPR008193; RNA_pol_Rpb11_13-16kDa_CS.
DR   InterPro; IPR033898; RNAP_AC19.
DR   Pfam; PF13656; RNA_pol_L_2; 1.
DR   SUPFAM; SSF55257; SSF55257; 1.
DR   PROSITE; PS01154; RNA_POL_L_13KD; 1.
PE   1: Evidence at protein level;
KW   Acetylation; Alternative splicing; Complete proteome;
KW   Direct protein sequencing; Disease mutation;
KW   DNA-directed RNA polymerase; Nucleus; Phosphoprotein;
KW   Reference proteome; Transcription.
FT   CHAIN         1    133       DNA-directed RNA polymerases I and III
FT                                subunit RPAC2.
FT                                /FTId=PRO_0000149316.
FT   MOD_RES       1      1       N-acetylmethionine.
FT                                {ECO:0000244|PubMed:19413330,
FT                                ECO:0000244|PubMed:22223895,
FT                                ECO:0000244|PubMed:22814378,
FT                                ECO:0000269|Ref.6}.
FT   VAR_SEQ      11    133       ISGLKTSMAEGERKTALEMVQAAGTDRHCVTFVLHEEDHTL
FT                                GNSLRYMIMKNPEVEFCGYTTTHPSESKINLRIQTRGTLPA
FT                                VEPFQRGLNELMNVCQHVLDKFEASIKDYKDQKASRNESTF
FT                                -> AIEELLKEAKRGKTRAETMGPMGWMKCPLASTNKRFLI
FT                                NTIKNTLPSHKEQDHEQKEGDKEPAKSQAQKEENPKKHRSH
FT                                PYKHSFRARGSASYSPPRKRSSQDKYEKRSNRR (in
FT                                isoform 2). {ECO:0000303|PubMed:14702039,
FT                                ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_035416.
FT   VARIANT      47     47       E -> K (in TCS2; dbSNP:rs767196650).
FT                                {ECO:0000269|PubMed:21131976}.
FT                                /FTId=VAR_064892.
FT   VARIANT      50     50       T -> I (in TCS2).
FT                                {ECO:0000269|PubMed:21131976}.
FT                                /FTId=VAR_064893.
FT   VARIANT      51     51       L -> R (in TCS2).
FT                                {ECO:0000269|PubMed:21131976}.
FT                                /FTId=VAR_064894.
FT   VARIANT      52     52       G -> E (in TCS2).
FT                                {ECO:0000269|PubMed:21131976}.
FT                                /FTId=VAR_064895.
FT   VARIANT      56     56       R -> C (in TCS2).
FT                                {ECO:0000269|PubMed:21131976}.
FT                                /FTId=VAR_064896.
FT   VARIANT      82     82       L -> S (in TCS2).
FT                                {ECO:0000269|PubMed:21131976}.
FT                                /FTId=VAR_064897.
FT   VARIANT      99     99       G -> S (in TCS2).
FT                                {ECO:0000269|PubMed:21131976}.
FT                                /FTId=VAR_064898.
SQ   SEQUENCE   133 AA;  15237 MW;  715DAEF2B22B1C76 CRC64;
     MEEDQELERK ISGLKTSMAE GERKTALEMV QAAGTDRHCV TFVLHEEDHT LGNSLRYMIM
     KNPEVEFCGY TTTHPSESKI NLRIQTRGTL PAVEPFQRGL NELMNVCQHV LDKFEASIKD
     YKDQKASRNE STF
//
